LUNG

Pulmonx (LUNG)

Pulmonx Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LUNG

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/06	07 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/06	07 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/06	07 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/06	06 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/06	06 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/06	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/06	06 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/06	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/06/01	05 : 38	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:LUNG	Pulmonx Corporation
2024/05/24	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/05/24	05 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUNG	Pulmonx Corporation
2024/05/23	06 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/05/18	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUNG	Pulmonx Corporation
2024/05/08	06 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/05/07	06 : 03	GlobeNewswire Inc.	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:LUNG	Pulmonx Corporation
2024/05/02	05 : 05	GlobeNewswire Inc.	Pulmonx Reports First Quarter 2024 Financial Results	NASDAQ:LUNG	Pulmonx Corporation
2024/04/11	05 : 05	GlobeNewswire Inc.	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024	NASDAQ:LUNG	Pulmonx Corporation
2024/04/03	05 : 05	GlobeNewswire Inc.	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer	NASDAQ:LUNG	Pulmonx Corporation
2024/03/16	06 : 00	GlobeNewswire Inc.	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:LUNG	Pulmonx Corporation
2024/03/08	10 : 02	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:LUNG	Pulmonx Corporation
2024/03/08	09 : 57	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:LUNG	Pulmonx Corporation
2024/03/08	09 : 54	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:LUNG	Pulmonx Corporation
2024/03/06	08 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/03/06	08 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/03/06	08 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/03/06	08 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
2024/03/01	06 : 31	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LUNG	Pulmonx Corporation
2024/02/28	06 : 07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:LUNG	Pulmonx Corporation
2024/02/27	10 : 48	Business Wire	Pulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-Zulassungsstudie	NASDAQ:LUNG	Pulmonx Corporation
2024/02/27	10 : 40	Business Wire	Pulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT II	NASDAQ:LUNG	Pulmonx Corporation